• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤“逃逸”假说的假设。

Assumptions of the tumor 'escape' hypothesis.

作者信息

Restifo Nicholas P, Antony Paul A, Finkelstein Steven E, Leitner Wolfgang W, Surman Deborah P, Theoret Marc R, Touloukian Christopher E

机构信息

National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

出版信息

Semin Cancer Biol. 2002 Feb;12(1):81-6. doi: 10.1006/scbi.2001.0399.

DOI:10.1006/scbi.2001.0399
PMID:11926416
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1508167/
Abstract

The reasons why cancer cells are not destroyed by the immune system are likely to be similar, in most cases, to the reasons why normal cells are not destroyed by the immune system. Unfortunately for tumor immunologists, these reasons have not yet been fully elucidated. What is known, however, is that the lack of autoimmune destruction of normal tissue after immune activation is a finely regulated, highly orchestrated sequence of events. Viewed in this light, it is interesting to conceptualize the derangement of the tumor genome not merely as an engine that enables cancer cells to dodge immune recognition. The dysregulation characteristic of the transformed genome is also what makes tumor immunity, a specialized form of autoimmunity, possible.

摘要

在大多数情况下,癌细胞未被免疫系统摧毁的原因可能与正常细胞未被免疫系统摧毁的原因相似。对肿瘤免疫学家来说不幸的是,这些原因尚未完全阐明。然而,我们已知的是,免疫激活后正常组织未发生自身免疫性破坏是一系列精细调节、高度协调的事件。从这个角度来看,将肿瘤基因组的紊乱不仅仅概念化为使癌细胞逃避免疫识别的引擎是很有趣的。转化基因组的失调特征也是使肿瘤免疫(一种特殊形式的自身免疫)成为可能的原因。

相似文献

1
Assumptions of the tumor 'escape' hypothesis.肿瘤“逃逸”假说的假设。
Semin Cancer Biol. 2002 Feb;12(1):81-6. doi: 10.1006/scbi.2001.0399.
2
Natural selection of tumor variants in the generation of "tumor escape" phenotypes.肿瘤逃逸表型产生过程中肿瘤变体的自然选择。
Nat Immunol. 2002 Nov;3(11):999-1005. doi: 10.1038/ni1102-999.
3
Strategies to overcome immune ignorance and tolerance.克服免疫忽视和耐受的策略。
Semin Cancer Biol. 2002 Feb;12(1):63-71. doi: 10.1006/scbi.2001.0397.
4
Signaling defects in anti-tumor T cells.抗肿瘤T细胞中的信号缺陷。
Immunol Rev. 2008 Apr;222:192-205. doi: 10.1111/j.1600-065X.2008.00606.x.
5
Conflicting consequences of immunity to cancer versus autoimmunity to neurons: insights from paraneoplastic disease.癌症免疫与神经元自身免疫之间冲突的后果:副肿瘤疾病的启示。
Eur J Immunol. 2014 Nov;44(11):3201-5. doi: 10.1002/eji.201445191.
6
Glycosphingolipids and antitumor immunity.糖鞘脂与抗肿瘤免疫
Biochim Biophys Acta. 1987 Jul 8;907(2):125-43. doi: 10.1016/0304-419x(87)90002-3.
7
Tumors and the danger model.肿瘤与危险模型。
Acta Biochim Pol. 2002;49(2):295-302.
8
[Dendritic cells and immune function in cancer].[癌症中的树突状细胞与免疫功能]
Pathol Biol (Paris). 1995 Dec;43(10):897-903.
9
Targeting neoantigens to augment antitumour immunity.靶向新抗原以增强抗肿瘤免疫力。
Nat Rev Cancer. 2017 Apr;17(4):209-222. doi: 10.1038/nrc.2016.154. Epub 2017 Feb 24.
10
Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?评论:免疫逃逸与肿瘤耐受:肿瘤如何逃避免疫监视?
Eur J Med Res. 2001 Aug 27;6(8):323-32.

引用本文的文献

1
A Holistic Perspective: Exosomes Shuttle between Nerves and Immune Cells in the Tumor Microenvironment.一种整体视角:外泌体在肿瘤微环境中的神经与免疫细胞之间穿梭。
J Clin Med. 2020 Oct 31;9(11):3529. doi: 10.3390/jcm9113529.
2
Combined treatment of murine fibrosarcoma with chemotherapy (Paclitaxel), radiotherapy, and intratumoral injection of dendritic cells.用化疗(紫杉醇)、放疗和瘤内注射树突状细胞联合治疗小鼠纤维肉瘤。
Ann Dermatol. 2014 Feb;26(1):53-60. doi: 10.5021/ad.2014.26.1.53. Epub 2014 Feb 17.
3
Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapy.在前列腺内树突状细胞注射和放疗期间对前列腺内淋巴细胞和细胞凋亡进行连续评估。
Immunotherapy. 2012 Apr;4(4):373-82. doi: 10.2217/imt.12.24.
4
The confluence of stereotactic ablative radiotherapy and tumor immunology.立体定向消融放疗与肿瘤免疫学的融合。
Clin Dev Immunol. 2011;2011:439752. doi: 10.1155/2011/439752. Epub 2011 Nov 15.
5
Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients.联合使用外部束放射治疗(EBRT)和肿瘤内注射树突状细胞作为高危软组织肉瘤患者的新辅助治疗。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):924-32. doi: 10.1016/j.ijrobp.2010.12.068. Epub 2011 Mar 11.
6
Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response.肿瘤的光动力疗法可以导致全身抗原特异性免疫反应的发展。
PLoS One. 2010 Dec 14;5(12):e15194. doi: 10.1371/journal.pone.0015194.
7
Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors.基于鼠白血病病毒的具有复制能力的逆转录病毒载体的组织和肿瘤特异性靶向
J Virol. 2006 Jul;80(14):7070-8. doi: 10.1128/JVI.00020-06.
8
Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cells.恶性胶质瘤的免疫治疗:着重于使用自体树突状细胞的主动特异性免疫治疗策略。
Childs Nerv Syst. 2005 Jan;21(1):7-18. doi: 10.1007/s00381-004-0994-3. Epub 2004 Sep 28.
9
The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.具有经典和非经典MHC I类分子表达改变的肿瘤变体的选择:对肿瘤免疫逃逸的影响
Cancer Immunol Immunother. 2004 Oct;53(10):904-10. doi: 10.1007/s00262-004-0517-9. Epub 2004 Apr 7.
10
Immunotherapy of cancer for the elderly patient: does allogeneic bone marrow transplantation after nonmyeloablative conditioning provide a new option?老年癌症患者的免疫治疗:非清髓性预处理后的异基因骨髓移植能否提供新的选择?
Cancer Immunol Immunother. 2004 Aug;53(8):659-76. doi: 10.1007/s00262-004-0503-2. Epub 2004 Apr 6.

本文引用的文献

1
Immunity to methylcholanthrene-induced sarcomas.对甲基胆蒽诱导肉瘤的免疫性。
J Natl Cancer Inst. 1957 Jun;18(6):769-78.
2
CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.CTLA-4介导的T细胞反应调节中的抑制作用:肿瘤免疫治疗中的机制与调控
Annu Rev Immunol. 2001;19:565-94. doi: 10.1146/annurev.immunol.19.1.565.
3
Purified MHC class I molecules inhibit activated NK cells in a cell-free system in vitro.纯化的I类主要组织相容性复合体分子在体外无细胞系统中可抑制活化的自然杀伤细胞。
Eur J Immunol. 2001 Mar;31(3):869-75. doi: 10.1002/1521-4141(200103)31:3<869::aid-immu869>3.0.co;2-a.
4
Countering the 'counterattack' hypothesis.反驳“反击”假说。
Nat Med. 2001 Mar;7(3):259. doi: 10.1038/85357.
5
Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis.有证据表明基因不稳定性在结直肠癌发生的早期阶段就会出现。
Cancer Res. 2001 Feb 1;61(3):818-22.
6
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.鉴定一种能够激活或抑制CD8(+) T细胞的CD11b(+)/Gr-1(+)/CD31(+)髓样祖细胞。
Blood. 2000 Dec 1;96(12):3838-46.
7
Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity.构建更优疫苗:凋亡性细胞死亡如何引发炎症并激活固有免疫和适应性免疫。
Curr Opin Immunol. 2000 Oct;12(5):597-603. doi: 10.1016/s0952-7915(00)00148-5.
8
Escape mechanisms in tumor immunity: a year 2000 update.肿瘤免疫逃逸机制:2000年最新进展
Crit Rev Oncog. 2000;11(2):97-133.
9
Regulatory T cells in autoimmmunity*.自身免疫中的调节性T细胞*。
Annu Rev Immunol. 2000;18:423-49. doi: 10.1146/annurev.immunol.18.1.423.
10
High frequency of autologous anti-melanoma CTL directed against an antigen generated by a point mutation in a new helicase gene.针对一种由新解旋酶基因中的点突变产生的抗原的自体抗黑色素瘤细胞毒性T淋巴细胞的高频率。
J Immunol. 2000 Jun 1;164(11):6057-66. doi: 10.4049/jimmunol.164.11.6057.